QFY goes live with intelligent building app for Amazon’s Alexa

Published 26-FEB-2018 12:49 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Quantify Technology Holdings Limited (ASX:QFY) has informed the market today that its Qumulus skill for Alexa is now available for customers to enable in the Alexa skills store.

Qumulus skill has passed Amazon’s certification requirements, and is part of the growing Qulumus suite of applications under development by QFY. It is a core part of the company’s goal of delivering its simple, easily installed Truly Intelligent Building solution.

Alexa is the AI technology behind Amazon Echo and other Alexa-enabled devices, and is comparable to Apple’s Siri and Google’s AI ‘Google Assistant’. Amazon customers can ask Alexa a broad array of questions and receive instantaneous responses using the Alexa cloud-based voice service.

To install Qumulus skill, users can search for it via the Alexa Skills store. This level of compatibility and accessibility is an important step for QFY as it looks to leverage the power and scale of Amazon’s AI technology to bring its intelligent building solutions to an enormous market.

As Amazon invests more into the Alexa platform, QFY will have increasingly more access to the changing world of voice control features.

This development is part of QFY’s primary goal, to allow its customers to have advanced control of their living spaces in a simple, straightforward way such as voice commands.

However this remains an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.

While QFY wants its customers to have a choice in how they use the technology, whether by voice, touch or application — voice control is increasingly the preferred method among consumers, and QFY identified this early on. Voice control has benefits in particular for elderly people and those with disabilities.

Qumulus skill is installed in QFY’s demonstration apartment on York Street, Sydney where it can be viewed by prospective clients and partners. It will also be available for demonstration in Harvey Norman’s Commercial Division.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free